<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mov Disord Clin Pract</journal-id>
<journal-id journal-id-type="iso-abbrev">Mov Disord Clin Pract</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2330-1619</journal-id>
<journal-id journal-id-type="publisher-id">MDC3</journal-id>
<journal-title-group>
<journal-title>Movement Disorders Clinical Practice</journal-title>
</journal-title-group>
<issn pub-type="epub">2330-1619</issn>
<publisher>
<publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
<publisher-loc>Hoboken, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31538084</article-id>
<article-id pub-id-type="pmc">6749814</article-id>
<article-id pub-id-type="doi">10.1002/mdc3.12816</article-id>
<article-id pub-id-type="publisher-id">MDC312816</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ADCY5–Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder</article-title>
<alt-title alt-title-type="right-running-head">ADCY5‐RELATED DYSKINESIA</alt-title>
<alt-title alt-title-type="left-running-head">N. Vijiaratnam et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mdc312816-cr-0001">
<name>
<surname>Vijiaratnam</surname>
<given-names>Nirosen</given-names>
</name>
<degrees>MBBS, BMedSci, FRACP</degrees>
<xref ref-type="aff" rid="mdc312816-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mdc312816-cr-0002">
<name>
<surname>Bhatia</surname>
<given-names>Kailash P.</given-names>
</name>
<degrees>MD, FRCP</degrees>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8185-286X</contrib-id>
<xref ref-type="aff" rid="mdc312816-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mdc312816-cr-0003">
<name>
<surname>Lang</surname>
<given-names>Anthony E.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="mdc312816-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mdc312816-cr-0004">
<name>
<surname>Raskind</surname>
<given-names>Wendy H.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="mdc312816-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mdc312816-cr-0005">
<name>
<surname>Espay</surname>
<given-names>Alberto J.</given-names>
</name>
<degrees>MD</degrees>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3389-136X</contrib-id>
<xref ref-type="aff" rid="mdc312816-aff-0005">
<sup>5</sup>
</xref>
<address>
<email>alberto.espay@uc.edu</email>
</address>
</contrib>
</contrib-group>
<aff id="mdc312816-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Royal Free Hospital</institution>
<named-content content-type="city">London</named-content>
<country country="GB">United Kingdom</country>
</aff>
<aff id="mdc312816-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology</named-content>
<institution>University College London</institution>
<named-content content-type="city">London</named-content>
<country country="GB">United Kingdom</country>
</aff>
<aff id="mdc312816-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medicine, Division of Neurology, Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital</named-content>
<institution>University of Toronto</institution>
<named-content content-type="city">Toronto</named-content>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="mdc312816-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Departments of Medicine and Psychiatry and Behavioral Sciences</named-content>
<institution>University of Washington</institution>
<named-content content-type="city">Seattle</named-content>
<named-content content-type="country-part">Washington</named-content>
<country country="US">USA</country>
</aff>
<aff id="mdc312816-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Neurology (J.S.), Kingston General Hospital, Canada; Department of Neurology (D.M.‐G.), Hospital Universitario Virgen del Rocío, Seville, Spain; and UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders (A.Z., A.J.E.), Department of Neurology</named-content>
<institution>University of Cincinnati</institution>
<named-content content-type="country-part">Ohio</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> Prof. Alberto J. Espay, Department of Neurology, UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders (A.Z., A.J.E.), University of Cincinnati, OH 45219, USA; E‐mail: <email>alberto.espay@uc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>6</volume>
<issue>7</issue>
<issue-id pub-id-type="doi">10.1002/mdc3.v6.7</issue-id>
<fpage>512</fpage>
<lpage>520</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 International Parkinson and Movement Disorder Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 International Parkinson and Movement Disorder Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MDC3-6-512.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>ABSTRACT</title>
<sec id="mdc312816-sec-0001">
<title>Background</title>
<p>The phenotypic spectrum of adenylyl cyclase 5 (ADCY5)‐related disease has expanded considerably since the first description of the disorder in 1978 as familial essential chorea in a multiplex family.</p>
</sec>
<sec id="mdc312816-sec-0002">
<title>Objective</title>
<p>To examine recent advances in the understanding of ADCY5‐related dyskinesia and outline a diagnostic approach to enhance clinical detection.</p>
</sec>
<sec id="mdc312816-sec-0003">
<title>Methods</title>
<p>A pragmatic review of the ADCY5 literature was undertaken to examine unique genetic and pathophysiological features as well as distinguishing clinical features.</p>
</sec>
<sec id="mdc312816-sec-0004">
<title>Results</title>
<p>With over 70 cases reported to date, the phenotype is recognized to be broad, although distinctive features include prominent facial dyskinesia, motor exacerbations during drowsiness or sleep arousal, episodic painful dystonic posturing increased with stress or illness, and axial hypotonia with delayed developmental milestones. Uncommon phenotypes include childhood‐onset chorea, myoclonus‐dystonia, isolated nongeneralized dystonia, and alternating hemiplegia.</p>
</sec>
<sec id="mdc312816-sec-0005">
<title>Conclusion</title>
<p>The ongoing expansion in clinical features suggests that ADCY5 remains underdiagnosed and may account for a proportion of “idiopathic” hyperkinetic movement disorders. Enhanced understanding of its clinical features may help clinicians improve the detection of complex or uncommon cases.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mdc312816-kwd-0001">episodic movement disorders</kwd>
<kwd id="mdc312816-kwd-0002">ADCY5 mutation</kwd>
<kwd id="mdc312816-kwd-0003">phenotypic spectrum</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<page-count count="9"></page-count>
<word-count count="6973"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>mdc312816</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.9 mode:remove_FC converted:17.09.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group id="mdc312816-ntgp-0001">
<fn id="mdc312816-note-0001">
<p>Relevant disclosures and conflicts of interest are listed at the end of this article.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>